Opinion: Cancer takes a firefighter for the ages
This is a news story made to be read 20 years from now, on a December morning decades in the future, when his friends and loved ones can’t stop missing
Related Articles
Gene therapy trials should emphasize transparency, not secrecy
After two recent deaths in gene therapy clinical trials, the industry needs to be more open to sharing information to protect participants.
The ‘skin in the game’ approach to health care spending has failed
It’s time to end the “skin in the game” experiment in health insurance and reform the broken system.
FDA approves drug to prevent or reduce the frequency of bleeding episodes for patients with hemophilia A with inhibitors or hemophilia B with inhibitors
Action The U.S. Food and Drug Administration has approved Alhemo (concizumab-mtci) for routine prophylaxis to prevent or reduce the frequency of bleeding
Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Hepatocellular Carcinoma — Thursday, January 23, 2025, San Francisco | Research To Practice
Thursday, January 23, 2025, San Francisco, California, 6:15 PM – 8:15 PM Pacific Time (9:15 PM – 11:15 PM Eastern Time) Location San Francisco Marriott…
Acute Myeloid Leukemia with NUP98-RARG Gene Fusion Similar to Acute Pr | OTT
Acute Myeloid Leukemia with NUP98-RARG Gene Fusion Similar to Acute Promyelocytic Leukemia: Case Report and Literature Review
Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
In a cohort of 166 patients with lung adenocarcinoma, Guégan et al. show that CD8+ T cell exhaustion is associated with resistance to immune checkpoint inhibitor. They…
Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas
The tumor microenvironments (TME) of diffuse large B-cell lymphoma (DLBCL) subgroups have remained poorly characterized. Here, we dissected the composition and spatial organization of the…
PSMA-RADS to improve evaluation and management of prostate cancer
Abdominal Radiology – Prostate-Specific Membrane Antigen (PSMA) positron emission tomography (PET) / computed tomography (CT) has become essential in managing prostate cancer, offering superior…
Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials.